Eris Lifesciences Limited

BSE: ERIS540596ISIN INE406M01024

Healthcare
Pharmaceuticals
BSE 500

Share price

₹1,217.45+40.05 (+3.40%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹1,737.00
52W low: ₹1,069.00
Off 52W high: -29.91%
1M return: +2.57%
3M return: -11.52%
6M return: -11.23%
1Y return: -23.89%
20D avg volume: 63,572
50 DMA: ₹1,233.59
200 DMA: ₹1,346.63

Key ratios Consolidated

Market cap: ₹16,891 Cr
Current price: ₹1,217.45
52W high / low: ₹1,737.00 / ₹1,069.00
Face value: ₹1.00
P/E: 23.51
P/B: 4.07
EPS (TTM): ₹51.78
Book value / share: ₹298.80
ROE: —
ROCE: 15.70%
Operating margin: —
Net margin: —
Debt / equity: 0.59
Net debt: ₹2,255 Cr
Interest cover: 4.31
Dividend yield: 0.59%
Dividend / share (TTM): ₹7.21
Payout: 13.92%
Cash conversion cycle: 91.9 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	892.37	873.25	756.56	807.45	792.41	773.00	705.30	727.45	738.95	719.72	550.92	486.30
	3.20	2.39	2.23	0.02	2.81	2.69	7.95	4.22	6.77	1.64	15.15	4.20
	895.57	875.64	758.79	807.47	795.22	775.69	713.25	731.67	745.72	721.36	566.07	490.49
	702.86	695.75	598.18	645.00	622.83	615.48	584.44	615.51	616.61	606.04	489.43	374.62
	107.86	94.27	68.12	105.85	82.58	70.10	68.28	69.43	72.16	66.47	51.17	38.91
	167.72	131.12	122.97	117.24	146.09	104.26	95.98	133.22	118.35	125.57	58.51	50.03
	149.19	153.42	136.85	138.08	137.45	144.43	121.45	125.39	125.63	132.62	102.47	98.67
	46.42	46.65	45.62	48.82	49.55	48.68	54.28	57.17	59.47	60.37	33.03	18.12
	73.42	72.07	69.57	70.34	69.08	70.51	77.25	81.20	80.48	75.94	53.90	45.72
	208.10	184.36	160.89	164.46	164.34	167.22	161.21	174.87	164.76	156.52	181.84	123.24
	192.71	179.89	160.61	162.47	172.39	160.21	128.81	116.16	129.11	115.32	76.65	115.87
	-35.90	0.00	0.00	-17.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	156.81	179.89	160.61	145.23	172.39	160.21	128.81	116.16	129.11	115.32	76.65	115.87
	-31.23	36.17	119.69	36.52	38.20	36.00	26.52	29.23	32.76	25.90	2.99	14.41
	187.14	143.32	279.10	108.83	134.47	125.10	102.35	86.93	96.35	89.42	79.63	101.46
	13.26	10.28	20.60	7.32	8.82	8.66	6.90	6.15	6.73	6.11	5.22	7.55
Key metrics
	276.65	298.61	275.80	264.39	291.02	279.40	260.34	254.53	269.06	251.63	163.58	179.71
	31.00%	34.20%	36.50%	32.70%	36.70%	36.10%	36.90%	35.00%	36.40%	35.00%	29.70%	37.00%
	21.00%	16.40%	36.90%	13.50%	17.00%	16.20%	14.50%	11.90%	13.00%	12.40%	14.50%	20.90%
	4.10%	—	3.90%	—	3.90%	—	3.20%	—	—	—	—	—
	12.60%	13.00%	7.30%	11.00%	7.20%	7.40%	28.00%	49.60%	—	—	—	—
	39.20%	14.60%	172.70%	25.20%	39.60%	39.90%	28.50%	-14.30%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	3,330	3,129	2,894	2,009	1,685	1,347	1,212	1,074	982.16	855.60
	7.84	7.75	18.36	23.82	11.15	26.09	8.71	15.40	31.69	26.41
	3,337	3,137	2,912	2,033	1,696	1,373	1,221	1,089	1,014	882.01
	2,642	2,481	2,423	1,602	1,292	930.94	826.07	758.11	696.50	569.78
	376.10	326.65	276.34	177.81	142.20	117.57	99.43	76.88	58.19	47.08
	539.05	490.56	473.12	201.51	206.33	141.72	177.01	73.24	108.93	89.84
	577.54	556.81	505.09	403.81	346.16	252.25	229.30	205.69	190.66	157.32
	187.51	192.67	231.29	84.80	26.17	4.15	1.80	2.16	22.89	10.55
	285.40	279.50	315.46	182.60	117.09	64.70	42.98	50.26	36.35	—
	717.81	656.90	657.36	550.45	449.90	351.32	313.72	328.46	292.89	242.21
	695.68	655.69	488.81	431.24	404.64	442.20	394.50	331.35	317.36	312.23
	-53.14	-17.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	642.54	638.45	488.81	431.24	404.64	442.20	394.50	331.35	317.36	312.23
	161.15	-8.97	114.20	34.19	30.48	36.41	39.36	34.84	26.21	17.25
	718.39	647.51	374.67	397.05	374.16	405.79	355.13	296.51	291.15	294.98
	51.46	45.33	25.85	28.82	28.10	29.89	26.16	21.61	21.15	—
Key metrics
	1,115	1,111	1,036	698.64	547.90	511.05	439.28	383.77	376.60	322.78
	33.50%	35.50%	35.80%	34.80%	32.50%	37.90%	36.20%	35.70%	38.30%	37.70%
	21.58%	20.70%	12.90%	19.80%	22.20%	30.10%	29.30%	27.60%	29.60%	34.50%
	—	15.70%	12.70%	—	—	—	—	—	—	—
	11.06%	8.10%	44.00%	19.20%	25.10%	11.20%	12.80%	9.40%	14.80%	—
	60.05%	72.80%	-5.60%	6.10%	-7.80%	14.30%	19.80%	1.80%	-1.30%	—
	—	241.13	910.01	—	—	—	—	—	—	—
	—	0.83	2.84	—	—	—	—	—	—	—
	—	0.59	0.76	—	—	—	—	—	—	—
	—	2,255	2,278	—	—	—	—	—	—	—
	—	91.9	58.2	—	—	—	—	—	—	—
Balance sheet
	—	7,366	7,033	—	—	—	—	—	—	—
	—	1,540	1,263	—	—	—	—	—	—	—
	—	54.74	199.74	—	—	—	—	—	—	—
	—	680.34	458.64	—	—	—	—	—	—	—
	—	436.82	334.83	—	—	—	—	—	—	—
	—	293.56	192.73	—	—	—	—	—	—	—
	—	708.37	662.07	—	—	—	—	—	—	—
	—	329.65	332.35	—	—	—	—	—	—	—
	—	2,077	1,381	—	—	—	—	—	—	—
	—	2,310	2,478	—	—	—	—	—	—	—
	—	1,354	696.20	—	—	—	—	—	—	—
	—	955.83	1,782	—	—	—	—	—	—	—
	—	3,896	3,272	—	—	—	—	—	—	—
Cash flow
	—	537.99	1,065	—	—	—	—	—	—	—
	—	-369.46	-79.97	—	—	—	—	—	—	—
	—	-313.53	-881.32	—	—	—	—	—	—	—
	—	296.86	155.00	—	—	—	—	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	482.24	443.99	277.31	315.29	650.50	578.64	404.77	399.73	428.75	456.69	341.30	324.41
	19.24	26.38	26.97	25.07	23.59	22.68	16.75	7.79	13.62	5.16	20.39	3.43
	501.48	470.37	304.28	340.36	674.09	601.32	421.52	407.52	442.37	461.85	361.69	327.85
	382.07	406.23	337.05	321.80	439.42	445.06	380.34	401.49	396.35	435.03	319.94	293.20
	18.74	19.99	22.53	17.05	20.29	24.12	9.83	10.93	23.19	24.40	17.74	23.75
	141.62	128.10	122.95	113.75	134.83	106.69	119.02	122.67	112.34	120.41	37.17	36.24
	82.01	90.84	78.67	82.75	85.42	93.78	81.41	87.04	89.72	103.75	79.52	80.69
	42.06	42.16	42.70	45.20	46.50	45.14	53.16	54.65	56.26	56.17	28.89	15.14
	40.88	39.98	38.82	38.66	39.30	37.60	43.38	46.68	46.16	45.55	29.14	28.08
	69.04	72.44	39.10	45.16	70.81	87.02	78.07	94.04	78.88	99.04	117.08	104.65
	119.41	64.14	-32.77	18.56	234.67	156.26	41.18	6.03	46.02	26.82	41.75	34.64
	-35.90	0.00	0.00	-14.67	0.00	0.00	0.00	—	—	—	—	—
	83.51	64.14	-32.77	3.89	234.67	156.26	41.18	6.03	46.02	26.82	41.75	34.64
	-45.64	15.84	-24.17	0.80	85.10	56.27	10.71	4.25	17.92	9.78	2.24	2.99
	129.15	48.30	-8.60	3.09	149.57	99.99	30.47	1.78	28.10	17.04	39.51	31.66
	9.32	3.49	-0.63	0.23	10.98	7.34	2.24	0.13	2.06	1.25	2.90	2.33
Key metrics
	166.45	146.28	48.75	87.75	320.47	239.00	137.72	107.36	148.44	128.54	99.78	77.86
	34.50%	32.90%	17.60%	27.80%	49.30%	41.30%	34.00%	26.90%	34.60%	28.10%	29.20%	24.00%
	26.80%	10.90%	-3.10%	1.00%	23.00%	17.30%	7.50%	0.40%	6.60%	3.70%	11.60%	9.80%
	3.50%	—	0.20%	—	6.50%	—	2.20%	—	—	—	—	—
	-25.90%	-23.30%	-31.50%	-21.10%	51.70%	26.70%	18.60%	23.20%	—	—	—	—
	-13.70%	-51.70%	-128.20%	73.60%	432.30%	486.80%	-22.90%	-94.40%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	1,519	1,822	1,698	1,487	1,331	1,216	1,109	1,020	896.54	760.60
	97.66	98.31	35.51	34.83	17.26	28.99	10.00	14.73	32.50	28.22
	1,616	1,920	1,733	1,522	1,348	1,245	1,119	1,035	929.04	788.82
	1,447	1,543	1,613	1,193	911.08	786.18	729.94	711.37	617.26	476.94
	78.31	83.99	68.35	96.29	114.13	117.57	99.43	76.88	58.19	47.08
	506.42	478.22	474.44	197.02	113.76	79.59	111.65	70.00	87.56	64.89
	334.27	340.62	361.92	331.67	252.52	222.18	207.02	191.73	166.77	130.84
	172.12	179.54	220.24	57.42	20.81	2.99	0.78	1.85	22.79	10.43
	158.34	154.38	181.77	102.39	64.66	51.45	37.64	44.88	31.59	21.79
	225.74	242.09	350.03	421.06	336.71	309.90	285.99	308.54	263.76	205.44
	169.34	376.72	120.05	328.83	436.91	458.54	388.89	323.59	311.78	311.89
	-50.57	-14.67	0.00	—	—	—	—	—	—	—
	118.77	362.05	120.05	328.83	436.91	458.54	388.89	323.59	311.78	311.89
	-53.17	118.00	42.66	29.12	38.90	41.35	38.29	32.32	26.39	18.23
	171.94	244.05	77.39	299.71	398.01	417.19	350.61	291.27	285.38	293.65
	12.41	17.86	5.69	22.04	29.27	30.70	25.82	21.23	20.75	—
Key metrics
	449.23	695.97	522.06	488.64	522.38	512.98	427.31	370.32	366.16	344.11
	29.58%	38.20%	30.80%	32.90%	39.30%	42.20%	38.50%	36.30%	40.80%	45.20%
	11.32%	13.40%	4.60%	20.20%	29.90%	34.30%	31.60%	28.50%	31.80%	38.60%
	—	13.30%	8.00%	—	—	—	—	—	—	—
	-25.31%	7.30%	14.20%	11.70%	9.50%	9.60%	8.70%	13.80%	17.90%	—
	-38.99%	215.40%	-74.20%	-24.70%	-4.60%	19.00%	20.40%	2.10%	-2.80%	—
	—	514.55	694.25	—	—	—	—	—	—	—
	—	2.31	9.07	—	—	—	—	—	—	—
	—	0.65	0.88	—	—	—	—	—	—	—
	—	2,050	2,129	—	—	—	—	—	—	—
	—	41.9	45.4	—	—	—	—	—	—	—
Balance sheet
	—	5,778	5,222	—	—	—	—	—	—	—
	—	1,023	627.54	—	—	—	—	—	—	—
	—	25.18	84.34	—	—	—	—	—	—	—
	—	307.16	236.19	—	—	—	—	—	—	—
	—	121.36	191.25	—	—	—	—	—	—	—
	—	63.21	86.43	—	—	—	—	—	—	—
	—	124.19	107.17	—	—	—	—	—	—	—
	—	219.35	216.08	—	—	—	—	—	—	—
	—	1,718	993.94	—	—	—	—	—	—	—
	—	2,076	2,213	—	—	—	—	—	—	—
	—	1,278	580.31	—	—	—	—	—	—	—
	—	797.62	1,633	—	—	—	—	—	—	—
	—	3,195	2,515	—	—	—	—	—	—	—
Cash flow
	—	563.94	701.87	—	—	—	—	—	—	—
	—	-694.16	-358.99	—	—	—	—	—	—	—
	—	71.06	-310.47	—	—	—	—	—	—	—
	—	49.39	7.62	—	—	—	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +11.04%
Sales CAGR 5Y: +10.44%
Profit CAGR 3Y: -15.04%
Profit CAGR 5Y: -6.99%
Sales YoY (TTM): -25.31%
Profit YoY (TTM): -38.99%

Consolidated

Sales CAGR 3Y: +22.92%
Sales CAGR 5Y: +20.89%
Profit CAGR 3Y: +20.06%
Profit CAGR 5Y: +12.76%
Sales YoY (TTM): +11.06%
Profit YoY (TTM): +60.05%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 54.74%

Quarter	September 2026	June 2026
Promoter %	54.74%	54.14%

Holder	Type	Holding	Previous	Change
Amit Indubhusan Bakshi	Promoter	42.96%	42.34%	+0.62%
Lilac Investments Limited	Public	8.62%	8.63%	-0.01%
Hdfc Small Cap Fund	Public	8.19%	8.33%	-0.14%
Inderjeet Singh Negi	Promoter	4.28%	4.29%	-0.01%
Rajendrakumar Rambhai Patel	Promoter	4.28%	4.29%	-0.01%
Franklin India Small Cap Fund	Public	3.76%	4.29%	-0.53%
Kaushal Kamleshkumar Shah	Promoter	3.22%	3.22%	0.00%
Hetal Rasiklal Shah	Public	2.12%	2.12%	0.00%
Bhikhalal Chimanlal Shah	Public	1.93%	1.93%	0.00%
Naishadh Vikram Shah	Public	1.66%	1.66%	0.00%
Rakesh Shah	Public	1.42%	1.43%	-0.01%
Uti-Flexi Cap Fund	Public	1.06%	1.58%	-0.52%
Dsp Small Cap Fund	Public	1.05%	—	—
Hsbc Mutual Fund - Hsbc Small Cap Fund	Public	1.03%	1.03%	0.00%
Eris Foundation	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Eris Lifesciences Limited	16,891	1,217.45	23.51	15.70%	+11.06% TTM	+60.05% TTM	-23.89%

Filings & corporate actions

Recent announcements

as attached4 Nov 2026 · AGM/EGM / Postal Ballot
The Company will host "Eris Investor Meet - 2026" on November 19, 202629 Oct 2026 · Company Update / Analyst / Investor Meet
as attached29 Oct 2026 · Company Update / Earnings Call Transcript
as attached26 Oct 2026 · Company Update / Analyst / Investor Meet
as attached26 Oct 2026 · Company Update / Investor Presentation
as attached26 Oct 2026 · Result / Financial Results
as attached26 Oct 2026 · Board Meeting / Outcome of Board Meeting
As Attached19 Oct 2026 · Company Update / Analyst / Investor Meet
As Attached19 Oct 2026 · Company Update / General
Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve Financial Results19 Oct 2026 · Board Meeting / Board Meeting
As Attached7 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
As Attached5 Oct 2026 · Company Update / Resignation of Director
As Attached28 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
As Attached25 Sep 2026 · AGM/EGM / AGM
Proceedings of 20th AGM held on September 25 202625 Sep 2026 · AGM/EGM / AGM
Proceedings of 29th Annual General Meeting of the Company held on 25th September 2026.25 Sep 2026 · AGM/EGM / AGM
As attached22 Sep 2026 · Company Update / Allotment of Equity Shares
as attached21 Sep 2026 · Company Update / General
As Attached11 Sep 2026 · Company Update / Resignation of Director
Eris Lifesciences Limited has informed the exchange about Rumor verification-Regulation 30 (11)10 Sep 2026 · Company Update / General
As attached9 Sep 2026 · Company Update / General
As Attached7 Sep 2026 · Company Update / Analyst / Investor Meet
as attached3 Sep 2026 · Company Update / Newspaper Publication
as attached.2 Sep 2026 · Company Update / Newspaper Publication
as attached2 Sep 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
as attached2 Sep 2026 · Others / Reg. 34 (1) Annual Report
as attached2 Sep 2026 · AGM/EGM / AGM
As Attached31 Aug 2026 · Others / Outcome without intimation
As Attached24 Aug 2026 · Company Update / Analyst / Investor Meet
as attached12 Aug 2026 · Company Update / Analyst / Investor Meet
As Attached10 Aug 2026 · Company Update / Analyst / Investor Meet
as attached6 Aug 2026 · Company Update / General
As Attached4 Aug 2026 · Company Update / Earnings Call Transcript
As Attached30 Jul 2026 · Company Update / Analyst / Investor Meet
As Attached30 Jul 2026 · Company Update / Allotment of ESOP / ESPS
As Attached29 Jul 2026 · Company Update / Analyst / Investor Meet
as attached29 Jul 2026 · Company Update / Investor Presentation
as attached29 Jul 2026 · Result / Financial Results
as attached29 Jul 2026 · Board Meeting / Outcome of Board Meeting
As Attached23 Jul 2026 · Company Update / Analyst / Investor Meet

Corporate actions

Purpose	Ex date	Record date	Payment date
Interim Dividend - Rs. - 7.2100	29 May 2026	29 May 2026	—
Interim Dividend - Rs. - 7.3500	13 Feb 2025	13 Feb 2025	—

Board meetings

26 Oct 2026 Board Meeting - Financial Results
29 Jul 2026 Board Meeting - Financial Results